Sharps Technology (STSS) EBITDA Margin (2025)
Sharps Technology recorded quarterly EBITDA Margin of 49794.56% in Q4 2025, up 59.43% quarter-over-quarter from 122747.94% in Q3 2025.
Sharps Technology's EBITDA Margin history runs 1 years deep, the most recent figure standing at 49794.56% for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Sharps Technology | 203.95 Mn | -56.54 Mn | 1.79 Mn | -49,794.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49,794.56% |
| Sep 30, 2025 | -122,747.94% |
| Jun 30, 2025 | -1,349.84% |